ID   JXQ-3D-001
AC   CVCL_E4KB
RX   PubMed=28029662;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=28029662
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,32.2
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C5838; Gallbladder sarcomatoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4KC ! JXQ-3D-002
OI   CVCL_E4KD ! JXQ-3D-003
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
RX   PubMed=28029662; DOI=10.18632/oncotarget.14146; PMCID=PMC5354913;
RA   Feng F.-L., Cheng Q.-B., Yang L., Zhang D.-D., Ji S.-L., Zhang Q.-Z.,
RA   Lin Y.-H., Li F.-G., Xiong L., Liu C., Jiang X.-Q.;
RT   "Guidance to rational use of pharmaceuticals in gallbladder
RT   sarcomatoid carcinoma using patient-derived cancer cells and whole
RT   exome sequencing.";
RL   Oncotarget 8:5349-5360(2017).
//